Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters

Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study

(2020) Ionut Bebu et al.   DIABETES CARE

Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life

(2020) Eshen Ang et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

(2020) Marcus Lind et al.   DIABETES CARE

Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes

(2019) Victoria Tyndall et al.   DIABETOLOGIA

The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies

(2019) Mark Evans et al.   Diabetes Therapy

Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)

(2019) Marion Fokkert et al.   BMJ Open Diabetes Research & Care

Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests

(2018) Timothy C. Dunn et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

(2018) Sara Charleer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

(2017) Thomas Haak et al.   Diabetes Therapy

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

(2017) Thomas Haak et al.   Diabetes Therapy

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

(2016) Jan Bolinder et al.   LANCET

Translating the A1C Assay Into Estimated Average Glucose Values

(2008) D. M. Nathan et al.   DIABETES CARE